NCT06000813 - REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 18, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

February 28, 2027

Conditions

Type 2 Diabetes (Adult Onset)Medication Adherence

Interventions

BEHAVIORAL

REACH-Es

REACH-Español is a mobile health platform adapted from the original REACH intervention to a Latino population with type 2 diabetes. The goal of REACH-Español is to improve diabetes medication adherence and glycemic management in this population.

BEHAVIORAL

ETAU

Participants will maintain care as usual (medication treatment and physician monitoring) in addition to a welcome SMS following enrollment, a SMS each time an HbA1c is collected with a link to a secure website that displays the result, and bi-monthly information on diabetes self-care education.

Trial Locations (1)

02114

Massachusetts General Hospital Diabetes Research Center, Boston

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Massachusetts General Hospital

OTHER